Literature DB >> 32472355

Vaccination mitigates influenza-induced muscular declines in aged mice.

Spencer R Keilich1,2, Erica C Lorenzo1,2, Blake L Torrance1,2, Andrew G Harrison2, Jenna M Bartley1,2, Laura Haynes3,4.   

Abstract

Influenza (flu) infection increases the risk for disability, falls, and broken bones in older adults. We have employed a preclinical model to examine the impact of flu on muscle function, which has a direct impact on fall risk. In mice, flu causes mobility and strength impairments with induction of inflammatory and muscle degradation genes that are increased and prolonged with aging. To determine if vaccination could reduce flu-induced muscle decrements, mice were vaccinated with flu nucleoprotein, infected, and muscle parameters were measured. Vaccination of aged mice resulted in significant protection from functional decrements, muscle gene expressions alterations, and morphological damage. Vaccination also improved protection from lung localized and systemic inflammation in aged mice. Despite documented decreased vaccine efficacy with aging, vaccination still provided partial protection to aged mice and represents a potential strategy to prevent flu-induced disability. These findings provide translational insight on ways to reduce flu-induced disability with aging. Graphical abstract .

Entities:  

Keywords:  Immunity; Inflammation; Influenza; Skeletal muscle; Vaccination

Mesh:

Substances:

Year:  2020        PMID: 32472355      PMCID: PMC7732952          DOI: 10.1007/s11357-020-00206-z

Source DB:  PubMed          Journal:  Geroscience        ISSN: 2509-2723            Impact factor:   7.713


  55 in total

1.  IL-4 acts as a myoblast recruitment factor during mammalian muscle growth.

Authors:  Valerie Horsley; Katie M Jansen; Stephen T Mills; Grace K Pavlath
Journal:  Cell       Date:  2003-05-16       Impact factor: 41.582

Review 2.  Cytokine-related aging process.

Authors:  John E Morley; Richard N Baumgartner
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2004-09       Impact factor: 6.053

3.  Hospital diagnoses, Medicare charges, and nursing home admissions in the year when older persons become severely disabled.

Authors:  L Ferrucci; J M Guralnik; M Pahor; M C Corti; R J Havlik
Journal:  JAMA       Date:  1997-03-05       Impact factor: 56.272

4.  IL-10 enhances the phenotype of M2 macrophages induced by IL-4 and confers the ability to increase eosinophil migration.

Authors:  Naoyuki Makita; Yoshiyuki Hizukuri; Kyoko Yamashiro; Masao Murakawa; Yasuhiro Hayashi
Journal:  Int Immunol       Date:  2014-09-29       Impact factor: 4.823

5.  IL-10 triggers changes in macrophage phenotype that promote muscle growth and regeneration.

Authors:  Bo Deng; Michelle Wehling-Henricks; S Armando Villalta; Ying Wang; James G Tidball
Journal:  J Immunol       Date:  2012-08-29       Impact factor: 5.422

Review 6.  Targeting B cell responses in universal influenza vaccine design.

Authors:  Kaval Kaur; Meghan Sullivan; Patrick C Wilson
Journal:  Trends Immunol       Date:  2011-09-21       Impact factor: 16.687

7.  Regulatory T Cells Promote Myositis and Muscle Damage in Toxoplasma gondii Infection.

Authors:  Richard M Jin; Sarah J Blair; Jordan Warunek; Reid R Heffner; Ira J Blader; Elizabeth A Wohlfert
Journal:  J Immunol       Date:  2016-11-28       Impact factor: 5.422

8.  Identification of cardiac myosin peptides capable of inducing autoimmune myocarditis in BALB/c mice.

Authors:  C L Pummerer; K Luze; G Grässl; K Bachmaier; F Offner; S K Burrell; D M Lenz; T J Zamborelli; J M Penninger; N Neu
Journal:  J Clin Invest       Date:  1996-05-01       Impact factor: 14.808

9.  Regulation of antinucleoprotein IgG by systemic vaccination and its effect on influenza virus clearance.

Authors:  Mark W Lamere; Amy Moquin; F Eun-Hyung Lee; Ravi S Misra; Patrick J Blair; Laura Haynes; Troy D Randall; Frances E Lund; Denise A Kaminski
Journal:  J Virol       Date:  2011-03-02       Impact factor: 5.103

10.  Role of interleukin-4 (IL-4) and IL-10 in serum immunoglobulin G antibody responses following mucosal or systemic reovirus infection.

Authors:  Alicia R Mathers; Christopher F Cuff
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

View more
  1 in total

Review 1.  Nonrespiratory sites of influenza-associated disease: mechanisms and experimental systems for continued study.

Authors:  Heather M Froggatt; Nicholas S Heaton
Journal:  FEBS J       Date:  2022-02-07       Impact factor: 5.622

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.